Engagement of the T cell antigen receptor (TCR) triggers a complex signaling network that culminates in the activation of effector and differentiation programs. The initial event is the activation of Lck, a tyrosine kinase of the SRC family that contains a unique N-terminal region, SRC-homology 3 (SH3) and SH2 domains that mediate protein-protein interactions, a catalytic domain and a C-terminal regulatory domain 1 . Lck that is recruited to the ligand-bound TCR autophosphorylates its own activating residue Tyr394 and then phosphorylates immunoreceptor tyrosine-based activation motifs in the TCR ζ-chain and in the TCR invariant CD3 chains. This recruits the cytosolic tyrosine kinase ZAP-70 ('ζ-chain of TCR-associated protein kinase 70') by binding the latter's SH2 domains. ZAP-70 consists of an N-terminal SH2 domain followed by interdomain A, a C-terminal SH2 domain, and interdomain B, which connects to the kinase domain. Interdomain B exists in an auto-inhibitory conformation that is relieved by Lck-mediated phosphorylation of ZAP-70 on Tyr315 and Tyr319, a prerequisite for interaction with the cell signaling molecules CBL (c-Cbl), VAV1, CRKII, Lck and PLC-γ, as well as full activation of . The kinase domain of ZAP-70 has two other tyrosine residues (Tyr492 and Tyr493) in the activation loop that are sites of autophosphorylation and/or phosphorylation by Lck 5 . ZAP-70 phosphorylates downstream adaptors such as LAT and LCP2 (more commonly known as SLP-76), with subsequent recruitment of adaptors and signaling molecules that form a multiprotein complex to promote full cellular activation 6 .
Engagement of the T cell antigen receptor (TCR) triggers a complex signaling network that culminates in the activation of effector and differentiation programs. The initial event is the activation of Lck, a tyrosine kinase of the SRC family that contains a unique N-terminal region, SRC-homology 3 (SH3) and SH2 domains that mediate protein-protein interactions, a catalytic domain and a C-terminal regulatory domain 1 . Lck that is recruited to the ligand-bound TCR autophosphorylates its own activating residue Tyr394 and then phosphorylates immunoreceptor tyrosine-based activation motifs in the TCR ζ-chain and in the TCR invariant CD3 chains. This recruits the cytosolic tyrosine kinase ZAP-70 ('ζ-chain of TCR-associated protein kinase 70') by binding the latter's SH2 domains. ZAP-70 consists of an N-terminal SH2 domain followed by interdomain A, a C-terminal SH2 domain, and interdomain B, which connects to the kinase domain. Interdomain B exists in an auto-inhibitory conformation that is relieved by Lck-mediated phosphorylation of ZAP-70 on Tyr315 and Tyr319, a prerequisite for interaction with the cell signaling molecules CBL (c-Cbl), VAV1, CRKII, Lck and PLC-γ, as well as full activation of ZAP-70 (refs. 2-4). The kinase domain of ZAP-70 has two other tyrosine residues (Tyr492 and Tyr493) in the activation loop that are sites of autophosphorylation and/or phosphorylation by Lck 5 . ZAP-70 phosphorylates downstream adaptors such as LAT and LCP2 (more commonly known as SLP-76), with subsequent recruitment of adaptors and signaling molecules that form a multiprotein complex to promote full cellular activation 6 .
There is a feedback loop that results in serine phosphorylation of Lck. ERK, one of the prominent serine-threonine kinases that is activated downstream of the TCR, phosphorylates Lck at Ser59 in the unique N-terminal domain 7 . Studies using recombinant proteins have shown that this phosphorylation diminishes the accessibility or affinity of phosphorylated proteins to Lck's SH2 domain 7 . The functional consequences of Lck S59 phosphorylation in primary mouse T cells is controversial 8, 9 , and its effect on signaling downstream of the TCR has not been studied.
TCR-mediated activation results in elevated intracellular Ca 2+ concentrations and activation of the Ca 2+ -calmodulin-dependent serine-threonine phosphatase calcineurin. Calcineurin is composed of a catalytically active A subunit (~61 kDa) and a small regulatory B subunit (~19 kDa) 10 . Among the critical transcription factors activated by TCR signaling are those of the NFAT family, in particular NFATC2 (NFAT1) and NFATC1 (NFAT2), which are required for the transcriptional upregulation of critical cytokines such as IFN-γ, TNF and interleukin 17 (IL-17) 11, 12 . NFAT proteins are constitutively phosphorylated on multiple serine and threonine residues, which causes them to be retained in the cytoplasm. Activated calcineurin dephosphorylates NFAT proteins, which leads to their translocation to the nucleus and the induction of transcription. The widely used immunosuppressive drugs cyclosporin A (CsA) and FK506 prevent the dephosphorylation of NFAT proteins by binding to cytosolic immunophilins (cyclophilin A and FKBP12, respectively), which in turn bind to and inhibit calcineurin and thus NFAT activity 13, 14 . Although NFAT proteins are generally believed to be the primary physiological targets of calcineurin in activated T cells, they have also been shown to positively regulate the transcription factor NF-κB through its interaction with the CBM complex (composed of the signaling molecules CARD11 (CARMA1), BCL10 and MALT1) and dephosphorylation of BCL10 after stimulation with phorbol ester and a Ca 2+ ionophore or via the TCR 15 . A constitutively active form of calcineurin promotes positive selection and lowers the threshold of antigenic stimulation in mature T cells, although its effects on proximal signaling pathways have not been addressed 16 . Notably, treatment with CsA or FK506 prevents the formation of T cell-antigenpresenting cell (APC) conjugates, which indicates that calcineurin might have non-transcriptionally-related activities downstream of the TCR 17 . The T cell-APC interaction is mediated by binding of the integrin LFA-1 (CD11a-CD18 or α L β 2 ) to ICAM-1 (ref. 18 ) after its phosphorylation on β-chain residues Thr758-Thr760, which is crucial for activation 19 .
CsA and FK506 inhibit activation of the mitogen-activated protein kinase (MAPK) p38 after stimulation with the phorbol ester PMA (phorbol 12-myristate 13-acetate) and the calcium ionophore ionomycin. The decrease in activation of p38, but not that of the MAPK ERK, was attributed to inhibition of the MAPK kinase MKK6 (refs. 20,21) . In contrast, stimulation of T cells via the TCR uses a MAPK-kinase-independent pathway to activate p38 (the alternative pathway), in which ZAP-70 phosphorylates p38 on Tyr323 (ref. 22 ). This results in autophosphorylation of p38 on Thr180 and an increase in kinase activity. Because MAPK kinases do not contribute to the alternative pathway, we sought to determine whether inhibition of calcineurin would also impair p38 activity downstream of the TCR, expecting no effect. However, inhibition of calcineurin did interfere with TCR-mediated activation of p38, which prompted us to investigate TCR-proximal signaling.
RESULTS

Inhibition of TCR-mediated activation of p38
Calcineurin antagonists diminish PMA-and ionomycin-mediated activation of p38 by inhibiting activation of the upstream kinase MKK6 (refs. 20,21) . Because stimulation via the TCR activates p38 by a MAPK-cascade-independent mechanism 22 , we anticipated that calcineurin inhibition would have no effect on p38 in this setting. Unexpectedly, when we activated Jurkat human T lymphocytes with cross-linked antibody to CD3 (anti-CD3), we found that treatment with CsA or FK506 diminished phosphorylation of the activation loop of p38 (Fig. 1a) . In contrast, the activation of another MAPK, ERK, was unaffected by calcineurin inhibition (Fig. 1a) . This finding was not unique to Jurkat cells, because primary human T cells responded in the same manner (Fig. 1b) . p38 can also be activated via the classic MAPK cascade in response to stresses such as osmotic shock. Unlike activation via the TCR, shock-induced phosphorylation of p38 (by treatment with sorbitol or ultraviolet irradiation (UV)) was unaffected by inhibition of calcineurin (data not shown). Given that the inhibitors used to inhibit calcineurin act via different immunophilins, these results indicated a positive role for calcineurin in the alternative activation of p38.
Calcineurin controls a subset of TCR proximal events Because p38 is directly activated by ZAP-70, a tyrosine kinase involved at the very earliest stage of TCR-mediated signaling, we sought to determine whether TCR-proximal signaling events upstream of p38 were sensitive to inhibition of calcineurin. The earliest tyrosine kinase in the signaling pathway is Lck, which phosphorylates TCR-ζ. Activation of Lck, as measured by phosphorylation of its Tyr394 residue, was unaffected by inhibition of calcineurin, as was phosphorylation of TCR-ζ (Fig. 1c,d) . In contrast, phosphorylation of the activating ZAP-70 kinase-domain residue Tyr493 was decreased by treatment with CsA or FK506, whereas phosphorylation of Tyr319 in the interdomain-B region was unaffected (Fig. 1e,f) . In addition to the phosphorylation of p38, the phosphorylation of other downstream molecules, such as LAT (on Tyr171) and SLP76 (on Tyr145) was diminished by such treatment (Fig. 1g,h ). Of note, these drugs had no effect on the phosphorylation of ERK or phospholipase C-γ1 (PLC-γ1), or on degradation of the NF-κB kinase inhibitor IκB (Fig. 1a,b ,i,j and Supplementary Fig. 1a,b) .
The effect of treatment with CsA or FK506 on some but not all of the TCR-induced signaling events led us to investigate whether the various pathways differed in their dependence on the most proximal signaling abnormality we detected, phosphorylation of ZAP-70 Y493 . The ZAP-70-deficient Jurkat cell variant P116 was stably transduced with vector encoding either wild-type ZAP-70 (ZAP-70 WT ) or mutant ZAP-70 with substitution of phenylalanine for the tyrosine at position 493 (ZAP-70 Y493F ), followed by stimulation via the TCR. Cells expressing ZAP-70 Y493F showed less phosphorylation of p38, LAT and SLP76 than that of cells expressing ZAP-70 WT (Fig. 1k) . In contrast, the Y493F substitution had little, if any, effect on phosphorylation of ERK and PLC-γ1; the latter has been shown to be dependent on phosphorylation of ZAP-70 Y319 (ref. 3) . These results recapitulated the observations obtained with the calcineurin inhibitors, which suggested that their effects on more distal signaling events were secondary to those caused by the diminished phosphorylation of ZAP-70 Y493 .
To confirm that the effects of CsA and FK506 were indeed due to inhibition of calcineurin, we analyzed TCR signaling in cells in which expression of the gene encoding calcineurin A was knocked down via small interfering RNA (siRNA). Because T cells express both isoforms of the catalytic subunit of calcineurin (the α-isoform, encoded by PPP3CA, and the β-isoform, encoded by PPP3CB), we used a 'cocktail' of validated siRNAs to achieve efficient knockdown of calcineurin expression in Jurkat cells and primary CD4 + T cells 15 . In agreement with published findings showing that the β-isoform is the predominant isoform 15 , siRNA targeting mRNA encoding the β-isoform (si-β) had a greater effect than that of siRNA targeting the mRNA encoding the α-isoform (si-α), and transfection of siRNAs targeting both resulted in almost complete knockdown (Fig. 2a,b) . Use of si-β and si-α reduced the abundance of protein by ~80% (Fig. 2a,b) . Knockdown resulted in a reduction in anti-TCR-induced phosphorylation of ZAP-70 Y493 and p38 in Jurkat cells and human CD4 + T cells (Fig. 2c,d) , which recapitulated the effects observed after treatment with CsA or FK506. To rule out the possibility of offtarget effects of siRNA treatment, we generated Jurkat cells that stably expressed 'codon-optimized' calcineurin A in which the sequences encoding multiple codons were altered in a manner that yielded the same amino acid sequence but conferred resistance to siRNAmediated knockdown. Treatment with calcineurin-targeting siRNAs reduced the expression of endogenous calcineurin A in both cell types, but the transfected calcineurin A remained unaltered in cells expressing the codon-optimized construct (Fig. 2e) . Maintenance of calcineurin expression prevented the decrease in the activation-induced phosphorylation of ZAP-70 Y493 , p38, and pSLP76 Y145 (Fig. 2e) , which indicated that the effect of the siRNA was indeed due to its targeting of calcineurin. Together these data demonstrated a role for calcineurin in the positive regulation of TCR signaling. 
A r t i c l e s
We determined the subcellular localization of calcineurin by confocal microscopy. Jurkat cells expressing yellow fluorescent protein (YFP)-tagged ZAP-70 were suspended at 37 °C and dropped onto coverslips coated with antibody to the tyrosine phosphatase CD45 (nonstimulatory control condition) or anti-CD3 (stimulatory condition) 23 . Cells were fixed after 2.5 or 10 min and were immunostained with antibodies specific for calcineurin and phosphorylated tyrosine. In the absence of stimulation, ZAP-70 was mainly cytosolic, whereas calcineurin was in punctate structures, and there was no colocalization of ZAP-70 with calcineurin (Fig. 3a) . After TCR ligation, however, there was distinct accumulation of ZAP-70-YFP and calcineurin with phosphorylatedtyrosine-rich areas at 2.5 min (Fig. 3a) , which indicated that both were recruited to the signaling microclusters. At 10 min, the extent of colocalization was diminished, although distinct colocalization was still visible in many microclusters (Fig. 3b) . Similar results were obtained for activated cells expressing ZAP-70-YFP that were imaged with anticalcineurin and antibody to phosphorylated TCR-ζ (Fig. 4a,b) .
To characterize the molecular nature of the calcineurin interactions in the activation-induced microclusters, we immunoprecipitated TCR-ζ from activated Jurkat cells and assessed its association with calcineurin by immunoblot analysis. Consistent with the data obtained by confocal microscopy, calcineurin did not co-precipitate with the TCR in unactivated cells but did so soon after activation with anti-CD3, in both Jurkat cells and primary human T cells (Fig. 5a,b) . Treatment of Jurkat cells or primary human CD4 + T cells with CsA or FK506 had no effect on TCR-induced recruitment of calcineurin (Fig. 5a,b) , demonstrating that calcineurin's catalytic activity is dispensable for translocation to the TCR. To determine whether the association of calcineurin with the TCR was the result of signaling, rather than being a consequence of anti-TCR-induced clustering, for example, we used JCam1.6 cells, a Jurkat cell derivative that lacks Lck 24 . Calcineurin did not co-immunoprecipitate with anti-TCR-ζ in the absence of Lck (Supplementary Fig. 1c ). Lck might be required because of its role in signal initiation and/or because it acts as an adaptor protein for calcineurin binding. We addressed this issue by stimulating Jurkat cells in the presence or absence of PP1, an inhibitor of the SRC family of kinases. Inhibition of Lck activity prevented the TCR-mediated recruitment of calcineurin to the TCR (Fig. 5c) . Consistent with the need for engagement of the TCR-proximal signaling machinery, treatment of Jurkat cells with PMA and ionomycin, which bypasses the TCR to activate T cells, failed to recruit calcineurin (Supplementary Fig. 1d ). We concluded that the translocation of calcineurin required tyrosine-phosphorylation events initiated by Lck.
Interaction of calcineurin with TCR-proximal signaling molecules
To determine which TCR-associated proteins interact with calcineurin, we activated Jurkat cells with anti-CD3 and lysed the cells, then immunoprecipitated proteins from the lysates with anti-calcineurin, followed by immunoblot analysis. As early as 2 min after activation, ZAP-70 and phosphorylated TCR-ζ were present in the calcineurin immunoprecipitates, an association that waned over 10-30 min and was mostly gone by 1 h after activation (Fig. 5d) , consistent with the very rapid recruitment of calcineurin to, and then attenuation of its association with, the TCR microclusters (Figs. 3 and 4) . Similar results were obtained with primary human T cells (Fig. 5e) . We assessed the requirement for ZAP-70 through the use of ZAP-70-deficient P116 cells. Although activation of Lck was normal in these cells, as expected, there was little recruitment of calcineurin to the TCR in the absence of ZAP-70 (Fig. 5f) . We investigated the role of ZAP-70's catalytic activity through use of the ZAP-70 kinase inhibitor piceatannol. Calcineurin still co-immunoprecipitated with TCR-ζ even when ZAP-70 activity was inhibited, as shown by markedly decreased phosphorylation of the ZAP-70 substrate LAT in these conditions (Fig. 5g) . These results indicated that calcineurin was recruited to ZAP-70 independently of signaling downstream of ZAP-70. Because calcineurin is best known for binding to and dephosphorylating NFAT transcription factors, we determined the kinetics of its association with NFAT1. Notably, the kinetics of the association of calcineurin with NFAT1 was the inverse of its association with the TCR, peaking at 10-30 min A r t i c l e s and slowly diminished thereafter but still persisting at 4 h after activation of the TCR (Fig. 5h) . We did not detect NFAT1 in lysates after immunoprecipitation with anti-TCR-ζ (Fig. 5i) , which, along with the appearance of non-TCR-associated calcineurin punctae at 10 min (Figs. 3 and 4) , was consistent with the notion that different pools of calcineurin participate in TCR-proximal signaling events and dephosphorylation of NFAT1.
Negative regulation of Lck S59 phosphorylation by calcineurin TCR-mediated activation of T cells induces the phosphorylation of Lck S59 , which in vitro inhibits Lck activity toward TCR-ζ immunoreceptor tyrosine-based activation motifs 7, 25 . We observed that activationinduced phosphorylation of Lck S59 was enhanced by inhibition of calcineurin activity, without any effect on Lck Y394 phosphorylation, in both Jurkat cells and primary human T cells (Fig. 6a,b) . TCRassociated Lck also had increased phosphorylation of Lck S59 after treatment of the cells with CsA or FK506 (Fig. 6c) . To investigate the induction of phosphorylation of Lck S59 in a more physiological context, we isolated T cells from the lymph nodes of AND mice (which have transgenic expression of TCR-αβ specific for moth cytochrome c (MCC) peptide (amino acids 88-103) presented on I-E k ) and activated the cells with their cognate antigen. As with TCR cross-linking, we found greater amounts of phosphorylated Lck S59 after treatment with CsA or FK506 than in cells not treated with those inhibitors (Supplementary Fig. 2a ).
To complement our findings obtained with the pharmacological inhibitors, we knocked down calcineurin expression using siRNA and analyzed the resultant cells. Notably, knockdown of expression of the calcineurin catalytic subunits enhanced the TCR-mediated phosphorylation of Lck S59 in both Jurkat cells and human CD4 + T cells, recapitulating the effects obtained with CsA and FK506 (Fig. 6d,e) . These results raised the possibility that phosphorylated Lck S59 is a direct target of calcineurin. To test our hypothesis, we immunoprecipitated TCR-ζ from Jurkat cells activated in the presence or absence of CsA or FK506, and an in vitro phosphatase assay was performed with recombinant human calcineurin ( Fig. 6f and Supplementary  Fig. 2b ). Calcineurin completely dephosphorylated Lck S59 ( Fig. 6f and Supplementary Fig. 2b ), which provided confirmation in vitro that Lck S59 was a substrate for this serine-threonine phosphatase.
Amino acid substitution at Lck S59 alters downstream signaling Although in vitro evidence obtained with recombinant proteins indicates that phosphorylation of Lck S59 inhibits its kinase activity, the effect of this post-translational modification on downstream signaling at the molecular level has not been addressed. Fig. 2c ). After activation with anti-CD3, T cells expressing Lck S59A had increased phosphorylation at Lck Y394 , ZAP-70 Y319 , ZAP-70 Y493 , LAT Y171 , p38 T180 and ERK T202,Y204 (Fig. 7a) . In contrast, cells expressing the phosphomimetic mutant Lck S59E had markedly blunted phosphorylation of these signaling intermediates (Fig. 7b) . In agreement with enhanced TCR signaling, anti-CD3-activated Jurkat cells expressing Lck S59A produced more IL-2 than did cells expressing Lck WT , whereas cells expressing Lck S59E produced less IL-2 than did Lck WT cells ( Supplementary  Fig. 2d ). This was TCR specific, as the cells responded similarly when stimulated with PMA and ionomycin (Supplementary Fig. 2d ).
T cell adhesion requires dephosphorylation of p-Lck S59
The immunosuppressive effects of calcineurin inhibition are largely ascribed to inhibition of NFAT-dependent gene expression. To determine whether inhibition of calcineurin activity in the TCR signalosome also contributes to immunosuppression, we searched for a calcineurindependent and NFAT-independent biological function. One possibility was T cell adhesion, a critical component in the initiation of the adaptive immune response. Activation via the TCR results in 'inside-out' signaling, in which the intracellular domain of LFA-1 is phosphorylated on Thr758, which rapidly results in conformational changes in the extracellular portion of LFA-1 that enhance binding to ICAM-1 (refs. 18,19) . Given that the increased LFA-1-mediated adhesion occurs in minutes, we reasoned that it was unlikely to require transcription and de novo protein synthesis. Indeed, LFA-1-dependent adhesion of anti-CD3-activated Jurkat or human CD4 + T cells to ICAM-1-coated plates was unaffected by treatment with the protein-synthesis inhibitor cycloheximide (Supplementary Fig. 3a) .
As expected, adhesion of activation-induced T cell was greatly dimin- A r t i c l e s ished by inhibition of Lck activity with PP1 (Fig. 8a,b) . Notably, treatment with CsA or FK506 also inhibited LFA-1-mediated adhesion induced by TCR signals; these inhibitors had little effect when adhesion was induced by activation with PMA and ionomycin (Fig. 8a,b) . To distinguish between NFAT-dependent activity and NFAT-independent activity we used VIVIT, a peptide reagent that mimics the major calcineurin-docking site on NFAT proteins and prevents binding of calcineurin to these proteins without impairing its catalytic activity 26, 27 . Treatment of cells VIVIT or the control peptide VEET had no effect on TCR-induced adhesion (Fig. 8a,b) . All treatment, except that with VEET, inhibited NFAT-dependent production of IL-2 (Supplementary Fig. 3b-d) . Treatment of cells with CsA or FK506 also had no effect on LFA-1 expression ( Supplementary  Fig. 4a,b) . However, phosphorylation of LFA-1 T758 was markedly diminished by treatment with CsA or FK506 (Fig. 8c) .
To determine whether inhibition of calcineurin affected TCRinduced LFA-1-mediated adhesion in response to a physiological antigen, we isolated purified T cells from the lymph nodes of AND mice and activated the cells with their cognate antigen (MCC peptide presented by I-E k ) in the presence or absence of CsA, FK506, VIVIT, VEET or anti-ICAM-1. The mouse fibroblast cell line DCEK, stably transfected with genes encoding I-E k and mouse ICAM-1, was used to present antigen. Antigen-induced binding of T cells to APCs was almost completely inhibited by treatment with CsA or FK506 and, as with anti-CD3-stimulated Jurkat T cells and human T cells, treatment with the NFAT inhibitor VIVIT had no effect (Fig. 8d) . Treatment with an ICAM-1-specific blocking antibody diminished the activation-induced adhesion of cells to the baseline adhesion found in the absence of antigen (Fig. 8d) , which demonstrated that the enhanced binding was entirely ICAM-1 dependent. Thus, calcineurin had an important positive role in this TCR-induced adhesion via NFATindependent modulation of the activation of LFA-1.
To determine whether calcineurin's effects on adhesion were mediated by dephosphorylation of phosphorylated Lck S59 , we studied the activation-induced adhesion of JCam1.6 cells expressing the Lck WT , Lck S59A or Lck S59E . Activated Lck WT -expressing cells bound to ICAM-1-coated plates, an event that was prevented by inhibition of calcineurin activity (binding in the presence of CsA or FK506 was diminished to the low binding observed in Lck-negative JCam1.6 cells) (Fig. 8e) . Lck S59A -expressing cells reproducibly bound better than Lck WT -expressing cells did (Fig. 8e) , consistent with the possibility of a negative role for phosphorylated Lck S59 in this process. In fact, activated cells expressing the Lck S59E phosphomimetic residue were unable to bind ICAM-1-coated plates at all (Fig. 8e) . Notably, although the cells expressed equivalent amounts of LFA-1 on their surface (Supplementary Fig. 4c ), treatment with CsA or FK506 had only a small (~25%) inhibitory effect on the adhesion of Lck S59A -expressing T cells (Fig. 8e) . We concluded that calcineurin was required for this activation-induced LFA-1-ICAM-1-mediated adhesion largely due to dephosphorylation of phosphorylated Lck S59 .
DISCUSSION
Major targets for calcineurin in activated T cells are members of the NFAT family of transcription factors, whose dephosphorylation allows them to migrate to the nucleus with increased DNA-binding and transcriptional activity. Many genes whose expression is repressed by inhibition of calcineurin (such as those encoding IL-2, the IL-2 receptor, IL-4, IFN-γ, TNF, the B-cell-stimulatory molecule CD40L and the ligand for the death receptor Fas) are critical for the proliferation and effector function of T cells, although in not all cases is this known to be due to inhibition of NFAT activity 28 . However, it is the inhibition of calcineurin-dependent NFAT activity that is thought to underlie the clinical usefulness of immunosuppressive drugs such as CsA and FK506. However, a few studies have provided evidence of regulation of TCR-proximal signaling by calcineurin. In one such case, treatment with CsA or FK506 increased LAT expression induced by TCR signaling 29 . In another, inhibition of calcineurin diminished TCR clustering in the immunological synapse 17 . The findings in our report have provided a molecular mechanism for, and the biological relevance of, calcineurin's role in TCR-proximal signaling.
In the resting state, calcineurin is a cytosolic protein. In the event of increased levels of intracellular Ca 2+ , calcineurin binds to and dephosphorylates members of the NFAT family, which allows both to migrate to the nucleus. It is thought that continued calcineurin phosphatase activity in the nucleus is needed to maintain NFAT in a transcriptionally active state while Ca 2+ levels remain elevated 30, 31 . The finding that in activated T cells, calcineurin first migrated to the plasma membrane was therefore a surprise. We found that maximal association of calcineurin with the TCR occurred within 2 min and slowly waned thereafter, whereas the association of calcineurin with NFAT1 increased over 10-30 min. Whether this represented a single pool of calcineurin that was initially diverted to plasma membrane TCRs and subsequently to intracellular NFAT or whether these erre two distinct pools of calcineurin remains to be determined. It seems likely that in the TCR signaling complex, calcineurin binds to phosphorylated ZAP-70, as the translocation of calcineurin to the TCR required the tyrosine kinase activity of Lck and the presence of its substrate, ZAP-70. In contrast, the kinase activity of ZAP-70 was dispensable for this, which indicated that further downstream signaling was not required. Furthermore, confocal microscopy showed that the calcineurin colocalized with phosphorylated ZAP-70 in activated T cells. Techniques that provide characterization of protein-protein interactions at higher resolution, such as fluorescence resonance energy transferor other super-resolution microscopy techniques, might prove useful in further elucidating calcineurin-interacting proteins in the TCR signaling complex. Phosphorylation of N-terminal residues of Lck was initially reported as a consequence of mitogenic stimulation 25 , and phosphorylated Lck S59 was subsequently identified as a target of ERK in phorbol-ester-stimulated and anti-TCR-stimulated T cells 7, 32 . Although one study has suggested that phosphorylation of Lck S59 is a positive event that prevents recruitment of the tyrosine phosphatase PTPN6 ('protein tyrosine phosphatase, non-receptor type 6'; SHP1) to the TCR 9 , T cells from mice with transgenic expression of an antigenspecific TCR that bear the Lck S59A mutation respond better to stimulation with antigen, with larger numbers of CD69 + cells and enhanced proliferation in response to tetramers of peptide and major histocompatibility complex, than do cells from wild-type mice 8 . Although TCRproximal signaling was not investigated in that study 8 , in vitro kinase assays with recombinant Lck have shown that its phosphorylation by ERK diminishes its activity toward sequences from its natural target, TCR-ζ 7 . In our report, Lck-deficient Jurkat T cells reconstituted with Lck WT , Lck S59A (which cannot accept a phosphate at Ala59) or Lck S59E (a phosphomimetic mutant) responded very differently to activation. Consistent with an inhibitory role for phosphorylated Lck S59 , TCRproximal signaling was enhanced in cells expressing Lck S59A and was markedly inhibited in those expressing Lck S59E . This held true for functional responses, such as activation-induced adhesion to ICAM-1-coated surfaces and IL-2 production. It is noteworthy that inhibition of calcineurin activity affected some signaling events but not others. Inhibition of calcineurin activity diminished phosphorylation of the proximal kinase ZAP-70 at residue Tyr493 but not at Tyr315 or Tyr319, and downstream signaling bifurcated, with decreases in phosphorylation of LAT Y171 and SLP76 Y145 but not of PLC-γ1 Y783 , and inhibition of p38 but not of ERK. This pattern was recapitulated in cells in which ZAP-70 Y493 could not be phosphorylated (ZAP-70 Y493F -expressing cells). These results were consistent with the notion that phosphorylated Lck S59 might change Lck's binding to and/or catalytic activity toward ZAP-70, which specifically affects phosphorylation of ZAP-70 Y493 , and might shed light on which downstream pathways are dependent on phosphorylated ZAP-70 Y493 .
The migration of immune cells into lymph nodes or areas of inflammation is a necessary step in an immune response. A key component in this event is LFA-1, a transmembrane integrin expressed on all T cells, as well as on other leukocytes, that binds to ICAM-1 (ref. 18 ). After T cells are activated, LFA-1 undergoes conformational changes from an inactive 'bent' form to an active 'extended' form that exposes ICAM-1-binding sites. This is accompanied by phosphorylation of LFA-1 on multiple residues, including α L -chain residues Ser1140 (which seems to be necessary for the conformational changes) and Thr758 (which regulates interactions with intracellular adaptors and enzymes, such as 14-3-3, that are involved in actin cytoskeleton rearrangement) 33, 34 . Although it has been shown that LFA-1 Thr758 is a major phosphorylation site in TCR-activated T cells 34 and that various isoforms of the kinase PKC can phosphorylate a peptide fragment of LFA-1 containing Thr758 in vitro, the physiologically relevant kinase(s) in vivo is (are) unknown 35 . Changes in LFA-1-dependent adhesion are among the earliest biological responses to TCR-mediated stimulation, occurring within minutes, and these are dependent on Lck and ZAP-70 activity 36, 37 . We found that adhesion was inhibited by treatment with CsA but was not affected by inhibition of NFAT activity, consistent with its rapid onset and independence from de novo protein synthesis. Notably, under some conditions, inhibition of calcineurin impairs TCR-mediated formation of T cell-APC conjugates 17 . The LFA-1-ICAM-1 interaction is critical in an immune response and has been targeted in the treatment of autoimmune disorders, such as plaque psoriasis, although reactivation of the human polyomavirus JC virus has precluded further use of such therapy 38 . T-cell-activation-induced degranulation by cytotoxic T cells is another early event that has been shown to be affected by inhibition of calcineurin 39, 40 , and we are tempted to speculate that this might also be due to its role in TCR-proximal signaling. We conclude that CsA and FK506 inhibit TCR-upregulated LFA-1-ICAM-1 binding by negatively regulating TCR-proximal signaling, which leads to a defect in cell adhesion. Given the critical role of cell adhesion in the adaptive immune response, this effect of CsA (or FK506) might be an important feature in their clinical utility.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
